Iron overload is associated with low anti-müllerian hormone in women with transfusion-dependent β-thalassaemia

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 118, Issue 7, 2011, Pages 825-831

  Chang, H H ^a,b   Chen, M J ^a   Lu, M Y ^a   Chern, J P S ^c   Lu, C Y ^a   Yang, Y L ^a   Jou, S T ^a   Lin, D T ^a   Yang, Y S ^a   Lin, K H ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c TAO YUAN GENERAL HOSPITAL   (Taiwan)

Author keywords

thalassaemia; Anti m llerian hormone; ferritin; hypogonadotrophic hypogonadism; iron overload

Indexed keywords

FERRITIN; MUELLERIAN INHIBITING FACTOR;

ADOLESCENT; ARTICLE; BETA THALASSEMIA; BLOOD SAMPLING; BLOOD TRANSFUSION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HORMONE DETERMINATION; HUMAN; HYPOGONADOTROPIC HYPOGONADISM; IRON OVERLOAD; MORBIDITY; PHENOTYPE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCHOOL CHILD; STRUCTURED QUESTIONNAIRE;

ADOLESCENT; ADULT; ANTI-MULLERIAN HORMONE; BETA-THALASSEMIA; BIOLOGICAL MARKERS; BLOOD TRANSFUSION; CASE-CONTROL STUDIES; CHILD; FEMALE; FERRITINS; HOSPITALS, UNIVERSITY; HUMANS; IRON OVERLOAD; PREDICTIVE VALUE OF TESTS; PROGNOSIS; QUESTIONNAIRES; RISK FACTORS; SENSITIVITY AND SPECIFICITY;

EID: 79955944456     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2011.02927.x     Document Type: Article

References (30)

1. Rund D, Rachmilewitz E,. Beta-thalassemia. N Engl J Med 2005; 353: 1135-46.
2. Olivieri NF,. The beta-thalassemias. N Engl J Med 1999; 341: 99-109.
3. Chern JP, Lin KH, Lu MY, Lin DT, Jou ST, Yang YL, et al., Beta-thalassemia major births after National Screening Program in Taiwan. Pediatr Blood Cancer 2008; 50: 58-61. (Pubitemid 350234266)
4. Olivieri NF, Nathan DG, MacMillan JH, Wayne AS, Liu PP, McGee A, et al., Survival in medically treated patients with homozygous beta-thalassemia. N Engl J Med 1994; 331: 574-8. (Pubitemid 24265699)
5. Olivieri NF, Brittenham GM,. Iron-chelating therapy and the treatment of thalassemia. Blood 1997; 89: 739-61. (Pubitemid 27121266)
6. Origa R, Piga A, Quarta G, Forni GL, Longo F, Melpignano A, et al., Pregnancy and beta-thalassemia: an Italian multicenter experience. Haematologica 2010; 95: 376-81.
7. Bajoria R, Chatterjee R,. Current perspectives of fertility and pregnancy in thalassemia. Hemoglobin 2009; 33 (Suppl 1): S131-5.
8. Italian Working Group on Endocrine Complications in Non-endocrine Diseases. Multicentre study on prevalence of endocrine complications in thalassaemia major. Italian Working Group on Endocrine Complications in Non-endocrine Diseases. Clin Endocrinol (Oxf) 1995; 42: 581-6.
9. Chern JP, Lin KH, Tsai WY, Wang SC, Lu MY, Lin DT, et al., Hypogonadotropic hypogonadism and hematologic phenotype in patients with transfusion-dependent beta-thalassemia. J Pediatr Hematol Oncol 2003; 25: 880-4. (Pubitemid 37413838)
10. Bergeron C, Kovacs K,. Pituitary siderosis. A histologic, immunocytologic, and ultrastructural study. Am J Pathol 1978; 93: 295-309. (Pubitemid 9047343)
11. Safarinejad MR,. Reproductive hormones and hypothalamic-pituitary-ovarian axis in female patients with homozygous beta-thalassemia major. J Pediatr Hematol Oncol 2010; 32: 259-66.
12. De Sanctis V, Vullo C, Katz M, Wonke B, Tanas R, Bagni B,. Gonadal function in patients with beta thalassaemia major. J Clin Pathol 1988; 41: 133-7. (Pubitemid 18053275)
13. Costin G, Kogut MD, Hyman CB, Ortega JA,. Endocrine abnormalities in thalassemia major. Am J Dis Child 1979; 133: 497-502. (Pubitemid 9211193)
14. Allegra A, Capra M, Cuccia L, Pulejo ML, Raineri L, Corselli F, et al., Hypogonadism in beta-thalassemic adolescents: a characteristic pituitary-gonadal impairment. The ineffectiveness of long-term iron chelation therapy. Gynecol Endocrinol 1990; 4: 181-91. (Pubitemid 20333185)
15. Weenen C, Laven JS, Von Bergh AR, Cranfield M, Groome NP, Visser JA, et al., Anti-Mullerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment. Mol Hum Reprod 2004; 10: 77-83. (Pubitemid 38196508)
16. Scheffer GJ, Broekmans FJ, Dorland M, Habbema JD, Looman CW, te Velde ER,. Antral follicle counts by transvaginal ultrasonography are related to age in women with proven natural fertility. Fertil Steril 1999; 72: 845-51. (Pubitemid 29505448)
17. Visser JA, de Jong FH, Laven JS, Themmen AP,. Anti-Mullerian hormone: a new marker for ovarian function. Reproduction 2006; 131: 1-9. (Pubitemid 43230697)
18. Fanchin R, Taieb J, Lozano DH, Ducot B, Frydman R, Bouyer J,. High reproducibility of serum anti-Mullerian hormone measurements suggests a multi-staged follicular secretion and strengthens its role in the assessment of ovarian follicular status. Hum Reprod 2005; 20: 923-7. (Pubitemid 40667836)
19. Hehenkamp WJ, Looman CW, Themmen AP, de Jong FH, Te Velde ER, Broekmans FJ,. Anti-Mullerian hormone levels in the spontaneous menstrual cycle do not show substantial fluctuation. J Clin Endocrinol Metab 2006; 91: 4057-63. (Pubitemid 44536885)
20. de Vet A, Laven JS, de Jong FH, Themmen AP, Fauser BC,. Antimullerian hormone serum levels: a putative marker for ovarian aging. Fertil Steril 2002; 77: 357-62. (Pubitemid 34083560)
21. Chen MJ, Yang WS, Yang JH, Hsiao CK, Yang YS, Ho HN,. Low sex hormone-binding globulin is associated with low high-density lipoprotein cholesterol and metabolic syndrome in women with PCOS. Hum Reprod 2006; 21: 2266-71. (Pubitemid 44530599)
22. Chen MJ, Yang WS, Chen CL, Wu MY, Yang YS, Ho HN,. The relationship between anti-Mullerian hormone, androgen and insulin resistance on the number of antral follicles in women with polycystic ovary syndrome. Hum Reprod 2008; 23: 952-7.
23. Koenig W, Vossen CY, Mallat Z, Brenner H, Benessiano J, Rothenbacher D,. Association between type II secretory phospholipase A2 plasma concentrations and activity and cardiovascular events in patients with coronary heart disease. Eur Heart J 2009; 30: 2742-8.
24. Bath LE, Wallace WH, Shaw MP, Fitzpatrick C, Anderson RA,. Depletion of ovarian reserve in young women after treatment for cancer in childhood: detection by anti-Mullerian hormone, inhibin B and ovarian ultrasound. Hum Reprod 2003; 18: 2368-74. (Pubitemid 37427819)
25. Kwee J, Schats R, McDonnell J, Themmen A, de Jong F, Lambalk C,. Evaluation of anti-Mullerian hormone as a test for the prediction of ovarian reserve. Fertil Steril 2008; 90: 737-43.
26. Gnoth C, Schuring AN, Friol K, Tigges J, Mallmann P, Godehardt E,. Relevance of anti-Mullerian hormone measurement in a routine IVF program. Hum Reprod 2008; 23: 1359-65. (Pubitemid 351770586)
27. Cunningham MJ, Macklin EA, Neufeld EJ, Cohen AR,. Complications of beta-thalassemia major in North America. Blood 2004; 104: 34-9. (Pubitemid 38879833)
28. Skordis N, Michaelidou M, Savva SC, Ioannou Y, Rousounides A, Kleanthous M, et al., The impact of genotype on endocrine complications in thalassaemia major. Eur J Haematol 2006; 77: 150-6.
29. Raiola G, Galati MC, De Sanctis V, Caruso Nicoletti M, Pintor C, De Simone M, et al., Growth and puberty in thalassemia major. J Pediatr Endocrinol Metab 2003; 16 (Suppl 2): 259-66. (Pubitemid 37259059)
30. Chern JP, Lin KH, Su YN, Lu MY, Jou ST, Lin DT, et al., Impact of a national beta-thalassemia carrier screening program on the birth rate of thalassemia major. Pediatr Blood Cancer 2006; 46: 72-6. (Pubitemid 41779321)